View in EDS HTML Full Text PDF Full Text

MIDD0301 – A first‐in‐class anti‐inflammatory asthma drug targets GABAA receptors without causing systemic immune suppression.

Saved in:
Bibliographic Details
Title: MIDD0301 – A first‐in‐class anti‐inflammatory asthma drug targets GABAA receptors without causing systemic immune suppression.
Authors: Zahn, Nicolas M.1, Huber, Alec T.1, Mikulsky, Brandon N.1, Stepanski, Mae E.1, Kehoe, Alexander S.1, Li, Guanguan1, Schussman, Melissa1, Rashid Roni, Mohammed S.1, Kodali, Revathi1, Cook, James M.1, Stafford, Douglas C.1, Arnold, Leggy A.1, Steeber, Douglas A.2
Source: Basic & Clinical Pharmacology & Toxicology. Jul2019, Vol. 125 Issue 1, p75-84. 10p.
Database: Environment Complete
Full text is not displayed to guests.
Description
ISSN:17427835
DOI:10.1111/bcpt.13206